Literature DB >> 19102684

Short communication: Absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia.

Yen T Duong1, Hongwei Jia, John A Lust, Albert D Garcia, Amanda J Tiffany, Walid Heneine, William M Switzer.   

Abstract

Clonal disorders of large granular lymphocytes (LGL) result in leukemia due to the expansion of a discrete subset of either CD3(+) T cells or natural killer (NK) cells. It has been hypothesized that a viral antigen acts as the initial stimulus causing the expansion of these cells. The possible involvement of human T cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in this disease has been studied but no conclusive evidence has linked either virus with LGL leukemia. In this study, we examined whether HTLV-3 or HTLV-4, two newly identified HTLV groups discovered in Central Africa in primate hunters, is involved in LGL leukemia. We developed two specific real-time PCR quantitative assays that are highly sensitive, capable of detecting 10 copies of HTLV-3 or HTLV-4 pol sequences in a background of 1 microg of DNA from human peripheral blood lymphocytes (PBL). We tested PBL DNA samples from 40 LGL leukemia patients in the United States and found that all samples were negative for HTLV-3 or HTLV-4 infection. These results suggest that HTLV-3 and HTLV-4 are not the causative agent of LGL leukemia.

Entities:  

Mesh:

Year:  2008        PMID: 19102684     DOI: 10.1089/aid.2008.0128

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.

Authors:  Susan Bell Nyland; Daniel J Krissinger; Michael J Clemente; Rosalyn B Irby; Kendall Thomas Baab; Nancy Ruth Jarbadan; Lubomir Sokol; Eric Schaefer; Jason Liao; David Cuthbertson; Pearlie Epling-Burnette; Ronald Paquette; Alan F List; Jaroslaw P Maciejewski; Thomas P Loughran
Journal:  Leuk Res       Date:  2012-03-02       Impact factor: 3.156

2.  Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization.

Authors:  Émilie Larocque; Marilène Halin; Sébastien Landry; Susan J Marriott; William M Switzer; Benoit Barbeau
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

3.  Discovery and characterization of auxiliary proteins encoded by type 3 simian T-cell lymphotropic viruses.

Authors:  Jocelyn Turpin; Chloé Journo; Nga Ling Ko; Flore Sinet; Alexandre Carpentier; Amandine Galioot; Dustin Edwards; Anne-Mieke Vandamme; Louis Gazzolo; Madeleine Duc Dodon; Antoine Gessain; Fatah Kashanchi; Ivan Balansard; Romain Lacoste; Renaud Mahieux
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

4.  Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.

Authors:  Émilie Larocque; Charlotte André-Arpin; Malgorzata Borowiak; Guy Lemay; William M Switzer; Madeleine Duc Dodon; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

5.  Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.

Authors:  Ana Treviño; Antonio Aguilera; Estrella Caballero; Rafael Benito; Patricia Parra; Jose M Eiros; Araceli Hernandez; Enrique Calderón; Manuel Rodríguez; Alvaro Torres; Juan García; Jose Manuel Ramos; Lourdes Roc; Goitzane Marcaida; Carmen Rodríguez; Matilde Trigo; Cesar Gomez; Raul Ortíz de Lejarazu; Carmen de Mendoza; Vincent Soriano
Journal:  Virol J       Date:  2012-03-23       Impact factor: 4.099

Review 6.  HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Viruses       Date:  2011-07-08       Impact factor: 5.048

7.  A gorilla reservoir for human T-lymphotropic virus type 4.

Authors:  Matthew LeBreton; William M Switzer; Cyrille F Djoko; Amethyst Gillis; Hongwei Jia; Michele M Sturgeon; Anupama Shankar; Haoqiang Zheng; Gerard Nkeunen; Ubald Tamoufe; Ahmadou Nana; Joseph Le Doux Diffo; Babila Tafon; John Kiyang; Bradley S Schneider; Donald S Burke; Nathan D Wolfe
Journal:  Emerg Microbes Infect       Date:  2014-01-22       Impact factor: 7.163

Review 8.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

9.  HTLV in South America: Origins of a silent ancient human infection.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Vânia Nakauth Azevedo; Luiz Fernando Almeida Machado; Izaura Maria Cayres Vallinoto; Maria Alice Freitas Queiroz; Greice de Lemos Cardoso Costa; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  Virus Evol       Date:  2020-07-24

Review 10.  Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1.

Authors:  Juliette Savoret; Jean-Michel Mesnard; Antoine Gross; Nathalie Chazal
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.